Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
FutureGen
company
About
FutureGen is an research and development manufacturer for antibody medication.
- 1 - 10
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥300M
- Industries
- Biotechnology,Manufacturing
- Founded date
- Jan 1, 2014
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥300M
FutureGen has raised a total of
¥300M
in funding over 2 rounds. Their latest funding was raised on
Mar 12, 2021 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 12, 2021 | Series B | ¥300M | 2 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
FutureGen is funded by 2 investors.
Zhongjin Qide
and Lilly Asia Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series B |
Lilly Asia Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
